452 results on '"Morozumi K"'
Search Results
2. Limited Sampling Strategies for Predicting Tacrolimus Exposure With Once Daily Extended Formulation in Kidney Transplant Recipients and Optimal Pre-Dosing Schedule.: Abstract# B965
3. Efficacy and Safety of Everolimus Based Immunosuppression On De Novo Kidney Transplantation With 5 Years Follow-Up Especially in Protocol Biopsy Findings and Donor Specific Antibody Production.: Abstract# B958
4. Changes in Non-Donor-Specific Antibodies After Human Leukocyte Antigen-Incompatible Renal Transplantation Would Also Be Worthy of Attention.: Abstract# B849
5. Proteinuria and Histopathological Change of Everolimus Based Immunosuppression On De Novo Kidney Transplantation With 5 Years Follow-Up in Protocol Biopsies.: Abstract# A194
6. Early Diagnosis and Treatment for Biopsy-Proven Subclinical Chronic Antibody Mediated Rejection After Renal Transplantation.: Abstract# A145
7. Chronic renal allograft nephropathy
8. Clinocopathological evaluation in non-episode biopsies of renal transplant allograft
9. One Year Post-Transplant but Not Pre-Transplant DSA Levels Predict Subclinical AMR in HLA-Incompatible Renal Transplantation Using Risk-Stratified Desensitization Therapy.: Abstract# 688: Poster Board #-Session: P156-I
10. Is There an Inhibitory Effect of Pre-Transplant Rituximab Therapy or Splenectomy on De Novo HLA Antibody Production after Renal Transplantation?: Abstract# 678: Poster Board #-Session: P146-I
11. Long Term Results of ABO-Incompatible Kidney Transplantation Using Cyclophosphamide and Splenectomy.: Abstract# 677: Poster Board #-Session: P145-I
12. Desensitization Protocol Using Intensified Dose of Mycophenolate Mofetile without Rituximab and Splenectomy for ABO-Incompatible Kidney Transplantation.: Abstract# 418
13. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration
14. Clinical success of NEORAL absorption profile
15. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?
16. Successful removal of αGal epitopes from vascular endothelial cells in pig kidneys by ex vivo and in vivo administration of endo-β-galactosidase C
17. Usefulness of two-point AUC 0–4 monitoring in maintenance renal transplant patients
18. Fate of patients undergoing pulmonary metastasectomy for metastatic urothelial carcinoma
19. Imaging of room-temperature ferromagnetic nano-domains at the surface of a non-magnetic oxide
20. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts
21. Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects
22. Effect of therapeutic ultrasound on local blood circulation: the relationship between changes in muscular oxygenation and tissue temperature
23. The cause-effect relation between physical function, physical ability, and health-related quality of life in elderly people with knee pain
24. Usefulness of monitoring of AUC0–4h during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation
25. Beneficial effect of antibody removal and enhanced immuno suppression in flow cytometry cross match-positive and ABO-incompatible renal transplantation
26. Removal of α-galactosyl antigens from vascular endothelial cells in pig organs by intravenous infusion of endo-β-galactosidase
27. 904 - Fate of patients undergoing pulmonary metastasectomy for metastatic urothelial carcinoma
28. Removal of αGal antigens by ex vivo perfusion of pig kidneys with endo-β-galactosidase C
29. Enzymatic digestion of α-gal antigens in pig organs by in vivo infusion of endo-β-galactosidase C
30. Long-term effects of chronic cyclosporine nephropathy on outcome of renal allografts
31. Pathologic characteristics of acute humoral rejection after abo-incompatible kidney transplantation
32. Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients
33. Changes in Non-Donor-Specific Antibodies After Human Leukocyte Antigen-Incompatible Renal Transplantation Would Also Be Worthy of Attention.
34. Limited Sampling Strategies for Predicting Tacrolimus Exposure With Once Daily Extended Formulation in Kidney Transplant Recipients and Optimal Pre-Dosing Schedule.
35. Proteinuria and Histopathological Change of Everolimus Based Immunosuppression On De Novo Kidney Transplantation With 5 Years Follow-Up in Protocol Biopsies.
36. Efficacy and Safety of Everolimus Based Immunosuppression On De Novo Kidney Transplantation With 5 Years Follow-Up Especially in Protocol Biopsy Findings and Donor Specific Antibody Production.
37. Early Diagnosis and Treatment for Biopsy-Proven Subclinical Chronic Antibody Mediated Rejection After Renal Transplantation.
38. Lower Incidence of Cytomegalovirus Infection With Everolimus Based Immunosuppression Versus Mycophenolate in De Novo Renal Transplants With 5 Years Follow-Up.
39. Establishment of Educational Program for Multiorgan Procurement From Deceased Donors
40. Acute Antibody-mediated Rejection Possibly Due to Anti–human Leukocyte Antigen DQB1 Antibodies after Renal Transplantation – Case Report
41. Comparative study of antibody removal before pig-to-baboon and human ABO-incompatible renal transplantation
42. Immunogenicity of Hanganutziu-Deicher antigens in pig-to-human xenotransplantation
43. Immunohistological study on the graft following all O- and xenotransplantation in recipients with preformed antibody
44. Changes in Blood Flow, Temperature and Muscle Endurance in Association with Cryotherapy
45. No Inhibitory Effect of Pre-Transplant Desensitization Treatment with Rituximab or Splenectomy on de Novo HLA Antibody Production in Renal Transplantation
46. T508 SHORT-TERM TRAINING EFFECTS ON THE RELATION BETWEEN FUNCTION, ABILITY, AND QUALITY OF LIFE IN ELDERLY PEOPLE WITH KNEE PAIN
47. POTENTIAL VALUE OF FOXP3 AND REGULATORY T CELL-RELATED GENE EXPRESSION MONITORING IN PERIPHERAL BLOOD AFTER RENAL TRANSPLANTATION
48. CLOSE RELATION BETWEEN CHRONIC ANTIBODY MEDIATED REJECTION AND DONOR SPECIFIC ANTIBODY AGAINST HLA CLASS II DRB, BUT NOT DQB.
49. Diagnosing cellular defects in an unexplained case of total fertilization failure
50. EXCELLENT GRAFT SURVIVAL USING CYCLOPHOSPHAMIDE WITHOUT∼ @RITUXIMAB INDUCTION IN ABO-INCOMPATIBLE RENAL TRANSPLANTATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.